| Accession | Title | Series type(s) | Organism(s) | Samples | GDS | Supplementary | Contact | Release date |
|---|---|---|---|---|---|---|---|---|
 Filter
|
Sarah J. Hill
|
|||||||
| GSE244027 |
Mapping BRD1 and HBO1 genomic binding in BRCA1 mutant cells
|
6 | Sarah J. Hill | Jan 11, 2024 | ||||
| GSE171513 |
Enhanced efficacy of aurora kinase inhibitors in G2/M checkpoint deficient TP53 mutant uterine carcinomas is linked to the summation of LKB1-AKT-p53 interactions [RNA-seq]
|
12 | Sarah J. Hill | May 08, 2021 | ||||
| GSE171514 |
Enhanced efficacy of aurora kinase inhibitors in G2/M checkpoint deficient TP53 mutant uterine carcinomas is linked to the summation of LKB1-AKT-p53 interactions [exome-seq]
|
6 | Sarah J. Hill | May 08, 2021 | ||||
| GSE171515 |
Enhanced efficacy of aurora kinase inhibitors in G2/M checkpoint deficient TP53 mutant uterine carcinomas is linked to the summation of LKB1-AKT-p53 interactions [WGS]
|
6 | Sarah J. Hill | May 08, 2021 | ||||
| GSE171516 |
Enhanced efficacy of aurora kinase inhibitors in G2/M checkpoint deficient TP53 mutant uterine carcinomas is linked to the summation of LKB1-AKT-p53 interactions
|
24 | Sarah J. Hill | May 07, 2021 |
